What does CUSIP 67421W109 represent in this 13F holders report?

CUSIP 67421W109 is the security identifier for OASMY - OASMIA PHARMACEUTICAL AB - ADR used to aggregate holder disclosures.

How many institutions held OASMY - OASMIA PHARMACEUTICAL AB - ADR in Q2 2019?

3 institutional investors reported OASMY - OASMIA PHARMACEUTICAL AB - ADR for Q2 2019. Use the holders table for investor-level position and value details.

OASMIA PHARMACEUTICAL AB - ADR (OASMY)

CUSIP: 67421W109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / ADR
Total 13F shares: 38,623
Share change: -43,864
Total reported value: $38,000
Price per share: $0.99
Number of holders: 3
Value change: -$101,993
Number of buys: 1
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 67421W109?
CUSIP 67421W109 identifies OASMY - OASMIA PHARMACEUTICAL AB - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 67421W109:

Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

Institutional Holders of OASMIA PHARMACEUTICAL AB - ADR (OASMY) as of Q2 2019

As of 30 Jun 2019, OASMIA PHARMACEUTICAL AB - ADR (OASMY) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,623 shares. The largest 3 holders included Compagnie Lombard Odier SCmA, UBS Group AG, and FNY Investment Advisers, LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.